14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $31.23 $31.23 Wednesday, 1st May 2024 IMGN stock ended at $31.23. During the day the stock fluctuated 0% from a day low at $31.23 to a day high of $31.23.
90 days $29.21 $31.25
52 weeks $10.31 $31.25

Historical ImmunoGen prices

Date Open High Low Close Volume
Mar 26, 2024 $31.23 $31.23 $31.23 $31.23 0
Mar 25, 2024 $31.23 $31.23 $31.23 $31.23 0
Mar 22, 2024 $31.23 $31.23 $31.23 $31.23 0
Mar 21, 2024 $31.23 $31.23 $31.23 $31.23 0
Mar 20, 2024 $31.23 $31.23 $31.23 $31.23 0
Mar 19, 2024 $31.23 $31.23 $31.23 $31.23 0
Mar 18, 2024 $31.23 $31.23 $31.23 $31.23 0
Mar 15, 2024 $31.23 $31.23 $31.23 $31.23 0
Mar 14, 2024 $31.23 $31.23 $31.23 $31.23 0
Mar 13, 2024 $31.23 $31.23 $31.23 $31.23 0
Mar 12, 2024 $31.23 $31.23 $31.23 $31.23 0
Mar 11, 2024 $31.23 $31.23 $31.23 $31.23 0
Mar 08, 2024 $31.23 $31.23 $31.23 $31.23 0
Mar 07, 2024 $31.23 $31.23 $31.23 $31.23 0
Mar 06, 2024 $31.23 $31.23 $31.23 $31.23 0
Mar 05, 2024 $31.23 $31.23 $31.23 $31.23 0
Mar 04, 2024 $31.23 $31.23 $31.23 $31.23 0
Mar 01, 2024 $31.23 $31.23 $31.23 $31.23 0
Feb 29, 2024 $31.23 $31.23 $31.23 $31.23 0
Feb 28, 2024 $31.23 $31.23 $31.23 $31.23 0
Feb 27, 2024 $31.23 $31.23 $31.23 $31.23 0
Feb 26, 2024 $31.23 $31.23 $31.23 $31.23 0
Feb 23, 2024 $31.23 $31.23 $31.23 $31.23 0
Feb 22, 2024 $31.23 $31.23 $31.23 $31.23 0
Feb 21, 2024 $31.23 $31.23 $31.23 $31.23 0
Click to get the best stock tips daily for free!

About ImmunoGen

ImmunoGen ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sunirine, a CD123-targeting ADC that is in Phase II clinical trial for treating acute myeloid leukemia and... IMGN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT